Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Arterra Bioscience SpA ( (IT:ARBS) ) has shared an announcement.
Arterra Bioscience announced a significant change in its ownership structure as shareholder Alberto Previtali now holds 15.20% of the company’s share capital, surpassing the 15% threshold. This change in shareholding could influence the company’s strategic decisions and stakeholder dynamics, given the substantial stake held by Previtali alongside other significant shareholders like Maria Gabriella Colucci and Intercos S.p.A.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company based in Naples, specializing in research and development in biotechnology. Founded in 2004 by CEO Gabriella Colucci, the company focuses on developing products and processes using living organisms for applications in cosmetics, agriculture, and nutraceuticals. Listed on the Euronext Growth Milan market since 2019, Arterra collaborates with various companies and research institutions, including a longstanding partnership with Intercos S.p.A. in the cosmetics sector.
Average Trading Volume: 13,060
Technical Sentiment Signal: Buy
Current Market Cap: €15.58M
Find detailed analytics on ARBS stock on TipRanks’ Stock Analysis page.